TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
CELU

Celularity Inc

Healthcare · Biotechnology

1.30$ +3.1% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Balance Sheet

Celularity Inc (CELU) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 107 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet CELU
Line item 2018 2019 2020 2021 2022 2023 2024 2025
0.0 521 431 414 401 144 133 107
0.0 37 72 37 34 20 21 12
0.0 28 54 37 14 0.2 0.7 6.2
0.0 28 54 37 14 0.7 6.2
3.9 3.1 6.6 5.2 7.0 10 14 4.7
3.5 3.2 3.9 9.5 5.3 5.8 5.4 0.6
4.0 66 90 91
131 127 123 123 120 7.3 7.3 7.3
394 271 125 123 121 11 9.2 7.8
0.2 384 412 315 202 103 124 145
0.2 21 27 26 62 67 54 81
3.0 3.1 38 6.4 14
5.3 0.0 5.4 9.3 5.8 14 23 26
36
-0.1 138 19 99 199 41 8.8 -38
0.0 -355 -564 -664 -645 -842 -900 -991
3.6 2.4 1.8 13 15 19 22 26

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?